Stockreport

Eli Lilly eyes Kelonia in $7B deal with $3.25B to be paid up front before investors could buy in. How to get in early [Yahoo! Finance]

Eli Lilly and Company  (LLY) 
Last eli lilly and company earnings: 4/23 06:25 am Check Earnings Report
US:NYSE Investor Relations: investor.lilly.com
PDF Eli Lilly (NYSE: LLY) is reportedly in talks to acquire cancer biotech Kelonia Therapeutics in a deal that could be worth more than $7 billion (1). The proposed acqui [Read more]